Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898235 · ClinicalTrials.gov registry record
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
A clinical trial of Multiple Myeloma, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT00898235: Recruiting study of Multiple Myeloma, sponsored by Boston Medical Center.
NCT00898235 is a study of Multiple Myeloma that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 10,000 participants, above the 524-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1808% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898235, a study of Multiple Myeloma, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future. PURPOSE: This research study is collecting samples from patients with amyloid diseases
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER laboratory biomarker analysis
- GENETIC clonality analysis
- GENETIC polymerase chain reaction
- GENETIC protein analysis
Study Locations (1)
Massachusetts
- Boston University Cancer Research Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2000-01 |
| Est. Completion | 2040-12 |
What NCT00898235 shows while recruiting
NCT00898235 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 524-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1808% higher).
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 5 interventions - of which biologic sample preservation procedure is the first listed.
NCT00898235 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00898235 about?
NCT00898235 is a clinical study titled "Collection of Samples and Clinical Data From Patients With Amyloid Diseases". RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future. PURPOSE: This research study is collecting samples from patients with amyloid diseases
What is the current status of trial NCT00898235?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2000-01. Estimated completion is 2040-12.
What conditions does trial NCT00898235 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT00898235?
The interventions under investigation include: biologic sample preservation procedure (OTHER), laboratory biomarker analysis (OTHER), clonality analysis (GENETIC), polymerase chain reaction (GENETIC), protein analysis (GENETIC).
Who is sponsoring clinical trial NCT00898235?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00898235 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00898235's enrollment target sits among peer trials
10,000 3rd of 438 higher than 436 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
- NCT01000883 · 10,000 participants
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia